News

TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING

Anti-MAG neuropathy refers to a rare auto-immune associated cause of peripheral neuropathy (PN). In this case, the person’s own immune system (specifically, the IgM monoclonal antibodies) attack nerve cells required for a healthy peripheral nervous system –resulting in a slowly progressive and debilitating condition. Patients often experience loss of mobility, muscle weakness, balance, numbness and …

TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING Read More »

Importance of Peripheral Neuropathy Recognized in Appropriations Act

Since 2019, the Foundation for Peripheral Neuropathy has been actively engaged in a campaign to increase federal funding for peripheral neuropathy research. We had an extraordinary breakthrough in fiscal year 2021, when Congress included “peripheral neuropathy” as an eligible condition for research funding from the Department of Defense’s Peer Reviewed Medical Research Program (PRMRP), and Congress …

Importance of Peripheral Neuropathy Recognized in Appropriations Act Read More »

PN Renewed in Senate Defense Bill

On July 27, 2023, the Senate Committee on Appropriations approved by a large bipartisan vote the Senate version of the fiscal year 2024 Defense Appropriations Act. As it has in the three previous years (FY21-23), the Committee included “peripheral neuropathy” as an eligible condition for receiving research grants from the Department of Defense’s Peer Reviewed Medical …

PN Renewed in Senate Defense Bill Read More »

Donor Advised Funds: A Great Way to Give

The Foundation for Peripheral Neuropathy (FPN) is a 100% donor supported 501(c)3 charitable organization. Through research funding, awareness, and patient education, our work advances our mission to improve the lives of patients living with peripheral neuropathy and accelerates the development of treatments, and one day, cures. A Donor Advised Fund (DAF) We view our supporters …

Donor Advised Funds: A Great Way to Give Read More »

Study Protocol on IgM Anti-Mag Neuropathy Released

The Foundation for Peripheral Neuropathy (FPN) is pleased that the IMAGiNe study protocol has been approved for publication in the Journal of The Peripheral Nervous System. The focus of this international study is a rare autoimmune cause of PN. It is identified by high levels of the IgM protein in the blood of affected patients, …

Study Protocol on IgM Anti-Mag Neuropathy Released Read More »